LeserbriefKommentar
Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants—Reply
JAMA · 2024
DOI: 10.1001/jama.2023.24533 ↗Kurz gefasst
Leserbrief in der Zeitschrift JAMA, 2024. Verfasst von Peter A Dargaville und 2 weiteren Autor:innen. Beteiligte Einrichtung: Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia. Hauptthemen laut MEDLINE: Infant, Premature, Pulmonary Surfactants, Surface-Active Agents. Die Arbeit nennt 5 Literaturangaben.
Themen: Neonatologie
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Infant, PrematurePulmonary SurfactantsSurface-Active AgentsHumansInfantInfant, NewbornLipoproteinsTreatment Outcome
Substanzen
LipoproteinsPulmonary SurfactantsSurface-Active Agents
Autor:innen und Institutionen
- Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia.
- Clinical Epidemiology and Biostatistics Unit, Murdoch Children's Research Institute, Melbourne, Australia.
- Neonatal Services, Royal Women's Hospital, Melbourne, Australia.
Zitieren
APA
Dargaville, P. A., Carlin, J. B., & Davis, P. G. (2024). Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants—Reply. JAMA. https://doi.org/10.1001/jama.2023.24533
Vancouver
Dargaville PA, Carlin JB, Davis PG. Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants—Reply. JAMA. 2024. doi:10.1001/jama.2023.24533
BibTeX
@article{Dargaville2024,
author = {Dargaville, Peter A and Carlin, John B and Davis, Peter G},
title = {Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants—Reply},
journal = {JAMA},
year = {2024},
doi = {10.1001/jama.2023.24533}
}
EUVIMED